Form 4 for BNTX BioNTech SE
Accepted 2026-04-23 16:02:44 ET · period of report 2026-04-22 · accession 0001955589-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| TI | 2026-04-23 16:02 | 2026-04-22 | BNTX | Poetting Sierk | COO | S - Sale | $110.56 | -50.0K | 399.4K | -11% | -$5.53M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-04-22 | S | D | 50,000 | $110.56 | 399,387 | I See Footnote | — | — | (F1) The ordinary shares are held by Tofino GmbH. The Reporting Person is the sole shareholder of Tofino GmbH and may be deemed to beneficially own the ordinary shares held by Tofino GmbH. |